Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Infants are exposed to per- and polyfluoroalkyl substances (PFAS) via feeding, yet the influence of PFAS on their gut microbiota remains poorly understood. In this study, 73 mother-preterm infant dyads were recruited in Shenzhen. We measured concentrations of 13 PFAS (PFBA, PFPeA, PFHxA, PFHpA, PFOA, PFNA, PFBS, PFHxS, PFOS, HFPO-DA, ADONA, 6:2 Cl-PFESA, and 8:2 Cl-PFESA) in the feeding substances (breast milk or formula) at the fourth week postpartum. Concurrently, fecal samples from preterm infants were collected for analysis of gut microbiota and metabolites. The highest mean concentrations were observed for two short-chain PFAS: PFBA and PFPeA. Eleven out of the 13 PFAS had detection rates exceeding 50 % and were included in subsequent analyses. Linear regression analysis indicated that daily intakes of PFBA, PFPeA, PFHxA, PFHpA, PFOA, PFNA, PFBS, and PFHxS were negatively associated with the ln-transformed PD_whole_tree index. Daily intakes of PFBA, PFBS, PFOA, and PFHxS were significantly linked with β diversity. The genus Veillonella was more abundant in the upper tertile groups of PFBA and PFBS. Moreover, daily intakes of PFHpA and PFOA were linked to predicted microbiome functions. Pathway analysis further revealed that PFAS daily intake was associated with synthesis or metabolism of multiple nutrients (including vitamins and amino acids). Notably, linear regression demonstrated that PFAS daily intake was negatively associated with levels of docosapentaenoic acid and docosahexaenoic acid. Our findings suggest that PFAS exposure through feeding may adversely affect the gut microbiota and normal development of preterm infants, potentially posing health risks.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecoenv.2025.118853DOI Listing

Publication Analysis

Top Keywords

gut microbiota
16
preterm infants
12
pfba pfpea
12
pfhpa pfoa
12
daily intakes
12
pfas
9
per- polyfluoroalkyl
8
polyfluoroalkyl substances
8
substances pfas
8
pfas exposure
8

Similar Publications

Cancer is a multifaceted disease driven by a complex interplay of genetic predisposition, environmental factors and lifestyle habits. With the accelerating pace of cancer research, the gut microbiome has emerged as a critical modulator of human health and immunity. Disruption in the gut microbial populations and diversity, known as dysbiosis, has been linked with the development of chronic inflammation, oncogenesis, angiogenesis and metastasis.

View Article and Find Full Text PDF

Gut microbiota dysbiosis in people living with HIV who have cancer: novel insights and diagnostic potential.

Front Immunol

September 2025

Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.

Background: People living with HIV(PLWH) are a high-risk population for cancer. We conducted a pioneering study on the gut microbiota of PLWH with various types of cancer, revealing key microbiota.

Methods: We collected stool samples from 54 PLWH who have cancer (PLWH-C), including Kaposi's sarcoma (KS, n=7), lymphoma (L, n=22), lung cancer (LC, n=12), and colorectal cancer (CRC, n=13), 55 PLWH who do not have cancer (PLWH-NC), and 49 people living without HIV (Ctrl).

View Article and Find Full Text PDF

Nutritional status, immunonutrition, and gut microbiome: a coming of age for immunotherapy?

Front Immunol

September 2025

Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

In the last decades, immunotherapy has revolutionized cancer treatment. Despite its success, a significant number of patients fail to respond, and the underlying causes of ineffectiveness remain poorly understood. Factors such as nutritional status and body composition are emerging as key predictors of immunotherapy outcomes.

View Article and Find Full Text PDF

Background: Recent research has increasingly underscored a significant correlation between gut microbiota and obstructive sleep apnea (OSA). Probiotics have emerged as promising adjunctive interventions for OSA. Metabolites and their related biochemical pathways have emerged as important contributors to the development of OSA.

View Article and Find Full Text PDF

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a rising health issue linked to poor diet and gut microbiota dysbiosis. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, high in polyphenols and anti-inflammatory nutrients, may help protect against MASLD. This study examined how adherence to the MIND diet relates to MASLD severity, focusing on hepatic steatosis, fibrosis, insulin resistance, inflammation, and gut microbiota diversity.

View Article and Find Full Text PDF